Home > Publications > Papers of Interest > Metronomic in children
Metronomic in children
Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child.
Demlova and al. from the team of Jaroslav Sterba in Brno have recently published in Current Oncology a case report entitled : Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child.
They report a child with anaplastic oligodendroglioma of the[...]
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen A Nonrandomized Controlled Trial
We are very excited to share the final results of the MEMMAT trial for the medullobastoma cohort- a gamme changer ! The results have been published by the JAMA Oncology journal. The article is entitled : Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen A Nonrandomized Controlled Trial MGHI is very proud[...]
Terapia metronomica: una opcion para el control del cancer en pacientes en tratamiento de intencion no curativa
We are very excited to proveid our first metronomic paper in spanish !
This short review entitled " Terapia metronomica: una opcion para el control del cancer en pacientes en tratamiento de intencion no curativa" has been written by Wendy Gomez Garcia, one our the MGHI members who works in the Hospital Infantil Dr. Robert Reid Cabral, Republica[...]
Treatment of Langerhans cell histiocytosis with a modified risk-adapted metronomic protocol-experience from India.
Narula G, Pradhan ND, Arora B, Banavali S .from the Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Center, Mumbai, India have just published in Pediatric Blood and Cancer a research article entitled: Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a[...]
vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma: a multicentre, open-label, randomised, phase 3 trial.
Giani Bisogno from the Haematology Oncology Division, Department of Women’s and Children’s Health, University of Padova, Padova, Italy on behalf of the the European paediatric Soft tissue sarcoma Study Group (EpSSG) have just pubisehd in the Lancet Oncology a randomized trial entitled: Vinorelbine and continuous low-dose cyclophosphamide as maintenance[...]
- previous page
- next page
